Compound and use thereof in the treatment of amyloidosis

Simon Kolstoe; Mark B. Pepys; Steven Ley; Angus Morrison; Vittorio Bellotti; Martin Smith

Compound and use thereof in the treatment of amyloidosis

Simon Kolstoe (Inventor), Mark B. Pepys (Inventor), Steven Ley (Inventor), Angus Morrison (Inventor), Vittorio Bellotti (Inventor), Martin Smith (Inventor)

University College London

Research output: Patent

Abstract

The present invention relates to compounds of formula (I) for stabilizing the tetrameric form of transthyretin, compounds for use in the treatment or prevention of amyloidosis, and agents and medicaments comprising such compounds.

Original language	English
Patent number	CA 2700596
IPC	WO2009040405 A1
Priority date	25/08/07
Publication status	Published - 2 Apr 2009

Cite this

@misc{a1085cee2dc343b78d83cf0e2307e71a,

title = "Compound and use thereof in the treatment of amyloidosis",

abstract = "The present invention relates to compounds of formula (I) for stabilizing the tetrameric form of transthyretin, compounds for use in the treatment or prevention of amyloidosis, and agents and medicaments comprising such compounds.",

author = "Simon Kolstoe and Pepys, {Mark B.} and Steven Ley and Angus Morrison and Vittorio Bellotti and Martin Smith",

year = "2009",

month = apr,

day = "2",

language = "English",

type = "Patent",

note = "CA 2700596; WO2009040405 A1",

}

TY - PAT

T1 - Compound and use thereof in the treatment of amyloidosis

AU - Kolstoe, Simon

AU - Pepys, Mark B.

AU - Ley, Steven

AU - Morrison, Angus

AU - Bellotti, Vittorio

AU - Smith, Martin

PY - 2009/4/2

Y1 - 2009/4/2

N2 - The present invention relates to compounds of formula (I) for stabilizing the tetrameric form of transthyretin, compounds for use in the treatment or prevention of amyloidosis, and agents and medicaments comprising such compounds.

AB - The present invention relates to compounds of formula (I) for stabilizing the tetrameric form of transthyretin, compounds for use in the treatment or prevention of amyloidosis, and agents and medicaments comprising such compounds.

M3 - Patent

M1 - CA 2700596

ER -

Compound and use thereof in the treatment of amyloidosis

Abstract

Fingerprint

Cite this